Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02560337
What this trial is testing

Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.

Who this might be right for
Ovarian Cancer
Vejle Hospital 26
Testing effectiveness (Phase 2)Study completedNCT03701295
What this trial is testing

Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement

Who this might be right for
Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLLLeukemia CutisRecurrent Acute Myeloid Leukemia+1 more
National Cancer Institute (NCI) 1
Early research (Phase 1)Ended earlyNCT00848601
What this trial is testing

Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma

Who this might be right for
Prostate CancerNon-Hodgkins Lymphoma
Astex Pharmaceuticals, Inc. 14
Large-scale testing (Phase 3)Active Not RecruitingNCT05653219
What this trial is testing

Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids

Who this might be right for
Primary Immune Thrombocytopenia
Novartis Pharmaceuticals 152
Testing effectiveness (Phase 2)Looking for participantsNCT07473167
What this trial is testing

Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients

Who this might be right for
Relapsed Large B-cell LymphomaRefractory Large B-cell LymphomaDiffuse Large B-cell Lymphoma (DLBCL)+3 more
TICAROS Co., Ltd. 98
Testing effectiveness (Phase 2)Study completedNCT00002501
What this trial is testing

Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 29
Early research (Phase 1)Active Not RecruitingNCT06824701
What this trial is testing

Tazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
University of Utah 24
Early research (Phase 1)Study completedNCT00058292
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University 44
Not applicableLooking for participantsNCT06864936
What this trial is testing

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
University of Maryland, Baltimore 30
Not applicableStudy completedNCT06463639
What this trial is testing

FLT3 Clonal Evolution in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
National Taiwan University Hospital 1,213
Early research (Phase 1)Study completedNCT01016730
What this trial is testing

Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma

Who this might be right for
AIDS-Related Kaposi SarcomaHIV InfectionRecurrent Kaposi Sarcoma
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT05250765
What this trial is testing

Comparison of Efficiency and Effectiveness of Two Types of Bonded Orthodontic Retainers: an RCT.

Who this might be right for
Relapse
University Hospital, Ghent 114
Not applicableNot Yet RecruitingNCT07008872
What this trial is testing

CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia

Who this might be right for
CD7+ LymphomaCD7+ Acute Leukemia
Qi deng 40
Testing effectiveness (Phase 2)Ended earlyNCT00462865
What this trial is testing

Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse

Who this might be right for
Breast Cancer
Brown University 18
Testing effectiveness (Phase 2)Study completedNCT04875195
What this trial is testing

Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)

Who this might be right for
Hodgkin's LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL)
Merck Sharp & Dohme LLC 66
Testing effectiveness (Phase 2)Study completedNCT00223639
What this trial is testing

New Medications to Treat Alcohol Dependence

Who this might be right for
Alcoholism
Bankole Johnson 29
Not applicableLooking for participantsNCT07497165
What this trial is testing

Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)Multiple Myeloma
Shanxi Bethune Hospital 48
Early research (Phase 1)Not Yet RecruitingNCT07335328
What this trial is testing

Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies

Who this might be right for
B-cell Non Hodgkin Lymphoma
Medical College of Wisconsin 24
Testing effectiveness (Phase 2)Study completedNCT01242631
What this trial is testing

Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer

Who this might be right for
Testicular CancerGerm Cell Cancer
Hannover Medical School 25
Large-scale testing (Phase 3)Study completedNCT02883153
What this trial is testing

Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Radboud University Medical Center 30
Next Page